As a GLP-1 receptor agonist, Semaglutide influences the gastrointestinal system
Regional Analysis North America Leading the GLP-1 Receptor Agonist Market North America accounted for the largest revenue share of 49.7% , supported by the high prevalence of type 2 diabetes and obesity, a developed healthcare system, and favorable reimbursement structures
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist marketed as Ozempic, Wegovy, and Rybelsus, does not typically appear on standard blood tests ordered during routine medical care
Skip to product section content Refine Buy 1 Get 1 FREE select same-brand Vitamins
However, seek medical attention if you experience severe pain, significant swelling, signs of an allergic reaction, or any unusual symptoms